Treatment of pediatric convulsive status epilepticus

被引:4
|
作者
Becker, Lena-Luise [1 ,2 ,3 ]
Gratopp, Alexander [4 ]
Prager, Christine [1 ,2 ]
Elger, Christian E. [1 ,2 ,5 ]
Kaindl, Angela M. [1 ,2 ,3 ]
机构
[1] Charite Univ med Berlin, Dept Pediat Neurol, Berlin, Germany
[2] Charite Univ med Berlin, Ctr Chron Sick Children, Berlin, Germany
[3] Charite Univ med Berlin, Inst Cell Biol & Neurobiol, Berlin, Germany
[4] Charite Univ med Berlin, Dept Pediat Pneumonol Immunol & Intens Care, Berlin, Germany
[5] Beta Clin, Bonn, Germany
来源
FRONTIERS IN NEUROLOGY | 2023年 / 14卷
关键词
status epilepticus; pediatric; treatment; epilepsy; benzodiazepine; REFRACTORY STATUS EPILEPTICUS; INTRAVENOUS-SODIUM VALPROATE; INTENSIVE-CARE TREATMENT; NEW-ONSET SEIZURES; RECTAL DIAZEPAM; INTRANASAL MIDAZOLAM; BUCCAL MIDAZOLAM; INTRAMUSCULAR MIDAZOLAM; OPEN-LABEL; ANTICONVULSANT MEDICATIONS;
D O I
10.3389/fneur.2023.1175370
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Status epilepticus is one of the most common life-threatening neurological emergencies in childhood with the highest incidence in the first 5 years of life and high mortality and morbidity rates. Although it is known that a delayed treatment and a prolonged seizure can cause permanent brain damage, there is evidence that current treatments may be delayed and the medication doses administered are insufficient. Here, we summarize current knowledge on treatment of convulsive status epilepticus in childhood and propose a treatment algorithm. We performed a structured literature search via PubMed and ClinicalTrails.org and identified 35 prospective and retrospective studies on children <18 years comparing two and more treatment options for status epilepticus. The studies were divided into the commonly used treatment phases. As a first-line treatment, benzodiazepines buccal/rectal/intramuscular/intravenous are recommended. For status epilepticus treated with benzodiazepine refractory, no superiority of fosphenytoin, levetirazetam, or phenobarbital was identified. There is limited data on third-line treatments for refractory status epilepticus lasting >30 min. Our proposed treatment algorithm, especially for children with SE, is for in and out-of-hospital onset aids to promote the establishment and distribution of guidelines to address the treatment delay aggressively and to reduce putative permanent neuronal damage. Further studies are needed to evaluate if these algorithms decrease long-term damage and how to treat refractory status epilepticus lasting >30 min.
引用
收藏
页数:10
相关论文
共 50 条
  • [1] Lidocaine treatment in pediatric convulsive status epilepticus
    Yildiz, Bilal
    Citak, Agop
    Ucsel, Raif
    Karabcoglu, Metin
    Aydinli, Nur
    Uzel, Nedret
    PEDIATRICS INTERNATIONAL, 2008, 50 (01) : 35 - 39
  • [2] Pharmacotherapy for Pediatric Convulsive Status Epilepticus
    Avantika Singh
    Coral M. Stredny
    Tobias Loddenkemper
    CNS Drugs, 2020, 34 : 47 - 63
  • [3] Pharmacotherapy for Pediatric Convulsive Status Epilepticus
    Singh, Avantika
    Stredny, Coral M.
    Loddenkemper, Tobias
    CNS DRUGS, 2020, 34 (01) : 47 - 63
  • [4] Treatment of Convulsive Status Epilepticus
    Grover, Eric H.
    Nazzal, Yara
    Hirsch, Lawrence J.
    CURRENT TREATMENT OPTIONS IN NEUROLOGY, 2016, 18 (03) : 1 - 20
  • [5] Treatment of convulsive status epilepticus
    Treiman, David M.
    NEUROBIOLOGY OF EPILEPSY AND AGING, 2007, 81 : 273 - 285
  • [6] Treatment of Convulsive Status Epilepticus
    Eric H. Grover
    Yara Nazzal
    Lawrence J. Hirsch
    Current Treatment Options in Neurology, 2016, 18
  • [7] Levetiracetam for treatment of convulsive status epilepticus: time to update childhood convulsive status epilepticus treatment guidelines?
    Pujar, Suresh
    Scott, Rod C.
    ARCHIVES OF DISEASE IN CHILDHOOD, 2021, 106 (05) : 418 - +
  • [8] Factors associated with treatment delays in pediatric refractory convulsive status epilepticus
    Fernandez, I. Sanchez
    Gainza-Lein, M.
    Abend, N. S.
    Anderson, A. E.
    Arya, R.
    Brenton, J. N.
    Carpenter, J. L.
    Chapman, K. E.
    Clark, J.
    Gaillard, W. D.
    Glauser, T. A.
    Goldstein, J. L.
    Goodkin, H. P.
    Helseth, A. R.
    Jackson, M. C.
    Kapur, K.
    Lai, Y. -C.
    McDonough, T. L.
    Mikati, M. A.
    Nayak, A.
    Peariso, K.
    Riviello, J. J., Jr.
    Tasker, R. C.
    Tchapyjnikov, D.
    Topjian, A. A.
    Wainwright, M. S.
    Wilfong, A.
    Williams, K.
    Loddenkemper, T.
    NEUROLOGY, 2018, 90 (19) : E1692 - E1701
  • [9] Time to Treatment in Pediatric Convulsive Refractory Status Epilepticus: The Weekend Effect
    Aguilar, Cristina Barcia
    Amengual-Gual, Marta
    Fernandez, Ivan Sanchez
    Abend, Nicholas S.
    Anderson, Anne
    Appavu, Brian
    Arya, Ravindra
    Brenton, J. Nicholas
    Carpenter, Jessica L.
    Chapman, Kevin E.
    Clark, Justice
    Farias-Moeller, Raquel
    Gaillard, William D.
    Gainza-Lein, Marina
    Glauser, Tracy
    Goldstein, Joshua L.
    Goodkin, Howard P.
    Guerriero, Rejean M.
    Huh, Linda
    Lai, Yi-Chen
    McDonough, Tiffani L.
    Mikati, Mohamad A.
    Morgan, Lyndsey A.
    Novotny, Edward J.
    Ostendorf, Adam
    Payne, Eric T.
    Peariso, Katrina
    Piantino, Juan
    Riviello, James
    Sannagowdara, Kumar
    Sheehan, Theodore
    Sands, Tristan T.
    Tasker, Robert C.
    Tchapyjnikov, Dmitry
    Topjian, Alexis A.
    Vasquez, Alejandra
    Wainwright, Mark S.
    Wilfong, Angus A.
    Williams, Korwyn
    Loddenkemper, Tobias
    PEDIATRIC NEUROLOGY, 2021, 120 : 71 - 79
  • [10] Treatment of convulsive and nonconvulsive status epilepticus
    Pang T.
    Hirsch L.J.
    Current Treatment Options in Neurology, 2005, 7 (4) : 247 - 259